Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan.
Department of Dentistry, School of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan.
Biomolecules. 2020 Sep 15;10(9):1321. doi: 10.3390/biom10091321.
Head and neck squamous cell carcinoma (HNSCC) is one of the most prevalent neoplasms worldwide. It is well recognized that environmental challenges such as smoking, viral infection and alcohol consumption are key factors underlying HNSCC pathogenesis. Other than major clinical interventions (e.g., surgical resection, chemical and radiotherapy) that have been routinely practiced over years, adjuvant anticancer agents from Traditional Herbal Medicine (THM) are proposed, either alone or together with conventional therapies, to be experimentally effective for improving treatment efficacy in different cancers including HNSCCs. At a cellular and molecular basis, THM extracts could modulate different malignant indices via distinct signaling pathways and provide better control in HNSCC malignancy and its clinical complications such as radiotherapy-induced xerostomia/oral mucositis. In this article, we aim to systemically review the impacts of THM in regulating HNSCC tumorous identities and its potential perspective for clinical use.
头颈部鳞状细胞癌(HNSCC)是全球最常见的肿瘤之一。众所周知,环境挑战如吸烟、病毒感染和饮酒是 HNSCC 发病机制的关键因素。除了多年来常规实践的主要临床干预(如手术切除、化学疗法和放射疗法)外,还提出了来自传统草药(THM)的辅助抗癌药物,单独或与常规疗法一起,在不同癌症中(包括 HNSCC)进行实验以提高治疗效果。在细胞和分子基础上,THM 提取物可以通过不同的信号通路调节不同的恶性指标,并在 HNSCC 恶性肿瘤及其临床并发症(如放射治疗引起的口干/口腔黏膜炎)的控制方面提供更好的效果。在本文中,我们旨在系统地综述 THM 调节 HNSCC 肿瘤特性的影响及其在临床应用中的潜在前景。